09606.HK
Duality Biotherapeutics, Inc.
HKSE · Healthcare · Biotechnology · CN
HKD 180.70
−1.53%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 8.64x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 6.96x
- Price / sales
- 11.98x
- Price / cash flow
- -25.54x
Enterprise value
- Enterprise value
- HKD 8.7B
- EV / sales
- 8.83x
- EV / EBITDA
- -4.84x
- EV / EBIT
- -4.76x
- Market cap
- HKD 11.8B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026